Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019
Authors:
- 12 March 2020
- journal article
- editorial
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 16 (3) , 271-274
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatmentBioScience Trends, 2020
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)BioScience Trends, 2020
- Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statementWorld Journal of Pediatrics, 2020
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne FlavivirusesViruses, 2018
- Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trialArchives of Virology, 2016
- Antiviral Treatment Guidelines for Middle East Respiratory SyndromeInfection & Chemotherapy, 2015
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaquesNature Medicine, 2013
- Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.2003
- Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damageHepatology, 2000
- Treatment of Severe Chloroquine PoisoningNew England Journal of Medicine, 1988